China Resources Pharmaceutical Group Limited (HKG: 3320)
Hong Kong
· Delayed Price · Currency is HKD 5.11
-0.02 (-0.39%)
Jan 21, 2025, 4:08 PM HKT
China Resources Pharmaceutical Group Revenue
China Resources Pharmaceutical Group had revenue of 64.30B CNY in the quarter ending June 30, 2024, with 4.71% growth. This brings the company's revenue in the last twelve months to 250.48B, up 11.50% year-over-year. In the year 2023, China Resources Pharmaceutical Group had annual revenue of 244.70B with 12.16% growth.
Revenue (ttm)
250.48B CNY
Revenue Growth
+11.50%
P/S Ratio
0.12
Revenue / Employee
3.43M CNY
Employees
72,986
Market Cap
31.73B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 244.70B | 26.52B | 12.16% |
| Dec 31, 2022 | 218.18B | -18.62B | -7.86% |
| Dec 31, 2021 | 236.81B | 36.38B | 18.15% |
| Dec 31, 2020 | 200.42B | -4.03B | -1.97% |
| Dec 31, 2019 | 204.45B | 14.76B | 7.78% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 26.04B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| JD Health International | 58.84B |
| WuXi Biologics | 18.39B |
| Sinopharm Group | 634.32B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 29.86B |
| Akeso | 2.01B |
China Resources Pharmaceutical Group News
- 3 months ago - Health product chain store CR Care to close all 19 branches in Hong Kong in November - Hong Kong Free Press